July 23, 2024

Uncategorized

New Releases from NCBI BookshelfFactors Contributing to Reductions in Patient Wait Times at Indian Health Service Emergency Department Facilities: A Mixed-Methods Assessment: Research Report.​Factors Contributing to Reductions in Patient Wait Times at Indian Health Service Emergency Department Facilities: A Mixed-Methods Assessment: Research Report.

This ASPE Research Report summarizes findings about factors affecting Emergency Department wait times and Primary Care appointment scheduling intervals, and

Uncategorized

New Releases from NCBI BookshelfRipretinib (Qinlock): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with advanced gastrointestinal stromal tumour who have received prior treatment with imatinib, sunitinib, and regorafenib [Internet].​Ripretinib (Qinlock): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with advanced gastrointestinal stromal tumour who have received prior treatment with imatinib, sunitinib, and regorafenib [Internet].

CADTH recommends that Qinlock be reimbursed by public drug plans for the treatment of adult patients with advanced gastrointestinal stromal

Scroll to Top